Global Immuno Oncology Assays Market by Indication (Bladder Cancer, Colorectal Cancer, Lung Cancer), Product (Consumables, Software), Technology, Application - Forecast 2024-2030- Product Image

Sale

Global Immuno Oncology Assays Market by Indication (Bladder Cancer, Colorectal Cancer, Lung Cancer), Product (Consumables, Software), Technology, Application - Forecast 2024-2030

Report
192 Pages
March 2024
Region: Global
360iResearch™
ID: 5337689

UP TO €844EUR$875USD£724GBP OFF until Dec 31^st 2024

The Immuno Oncology Assays Market size was estimated at USD 6.26 billion in 2023, USD 7.21 billion in 2024, and is expected to grow at a CAGR of 15.26% to reach USD 16.93 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Immuno Oncology Assays Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Immuno Oncology Assays Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Immuno Oncology Assays Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., BioAgilytix Labs, LLC, Charles River Laboratories International, Inc., ElsaLys Biotech S.A., Eurofins DiscoverX Products, LLC, HTG Molecular Diagnostics, Inc., Illumina, Inc., Merck KGaA, NanoString Technologies, Inc., NeoGenomics Laboratories, Inc., PerkinElmer, Inc., QIAGEN GmbH, Sartorius AG, Thermo Fisher Scientific, Inc., and Twist Bioscience Corporation.

Market Segmentation & Coverage

This research report categorizes the Immuno Oncology Assays Market to forecast the revenues and analyze trends in each of the following sub-markets:

Indication
- Bladder Cancer
- Colorectal Cancer
- Lung Cancer
- Melanoma
Product
- Consumables
- Software
Technology
- Flow Cytometry
- Immunoassay
- Next-Generation Sequencing
- Polymerase Chain Reaction
Application
- Clinical Diagnostics
- Research

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Immuno Oncology Assays Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Immuno Oncology Assays Market?
What are the technology trends and regulatory frameworks in the Immuno Oncology Assays Market?
What is the market share of the leading vendors in the Immuno Oncology Assays Market?
Which modes and strategic moves are suitable for entering the Immuno Oncology Assays Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Immuno Oncology Assays Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing incidences of cancer and adoption of targeted therapy over other treatment options
5.1.1.2. Development of bioinformatic tools enhancing the drug development process
5.1.1.3. Rise in healthcare expenditure and healthcare insurance
5.1.2. Restraints
5.1.2.1. Unfavorable regulatory and reimbursement scenario
5.1.3. Opportunities
5.1.3.1. Technological advancement and R&D for the treatment of cancer
5.1.3.2. Emergence of companion diagnostics
5.1.4. Challenges
5.1.4.1. Lack of healthcare professions for device operation
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Immuno Oncology Assays Market, by Indication

6.1. Introduction
6.2. Bladder Cancer
6.3. Colorectal Cancer
6.4. Lung Cancer
6.5. Melanoma

7. Immuno Oncology Assays Market, by Product

7.1. Introduction
7.2. Consumables
7.3. Software

8. Immuno Oncology Assays Market, by Technology

8.1. Introduction
8.2. Flow Cytometry
8.3. Immunoassay
8.4. Next-Generation Sequencing
8.5. Polymerase Chain Reaction

9. Immuno Oncology Assays Market, by Application

9.1. Introduction
9.2. Clinical Diagnostics
9.3. Research

10. Americas Immuno Oncology Assays Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Immuno Oncology Assays Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Immuno Oncology Assays Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

14.1. Key Company Profiles
14.1.1. Agilent Technologies, Inc.
14.1.2. Bio-Rad Laboratories, Inc.
14.1.3. BioAgilytix Labs, LLC
14.1.4. Charles River Laboratories International, Inc.
14.1.5. ElsaLys Biotech S.A.
14.1.6. Eurofins DiscoverX Products, LLC
14.1.7. HTG Molecular Diagnostics, Inc.
14.1.8. Illumina, Inc.
14.1.9. Merck KGaA
14.1.10. NanoString Technologies, Inc.
14.1.11. NeoGenomics Laboratories, Inc.
14.1.12. PerkinElmer, Inc.
14.1.13. QIAGEN GmbH
14.1.14. Sartorius AG
14.1.15. Thermo Fisher Scientific, Inc.
14.1.16. Twist Bioscience Corporation
14.2. Key Product Portfolio

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing

List of Figures

FIGURE 1. IMMUNO ONCOLOGY ASSAYS MARKET RESEARCH PROCESS
FIGURE 2. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, 2023 VS 2030
FIGURE 3. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. IMMUNO ONCOLOGY ASSAYS MARKET DYNAMICS
FIGURE 7. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 8. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 10. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 12. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 14. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. IMMUNO ONCOLOGY ASSAYS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. IMMUNO ONCOLOGY ASSAYS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. IMMUNO ONCOLOGY ASSAYS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 6. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY BLADDER CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY MELANOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 11. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 14. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 19. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 35. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 36. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 37. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 39. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 40. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 41. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 55. AUSTRALIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. CHINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 57. CHINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. CHINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 59. CHINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. INDIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 61. INDIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. INDIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 63. INDIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 67. INDONESIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. JAPAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 69. JAPAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. JAPAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 71. JAPAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 75. MALAYSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 79. PHILIPPINES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 83. SINGAPORE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 87. SOUTH KOREA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. TAIWAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 91. TAIWAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. THAILAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 93. THAILAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. THAILAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 95. THAILAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. VIETNAM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 99. VIETNAM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 105. DENMARK IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 106. DENMARK IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 107. DENMARK IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 108. DENMARK IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. EGYPT IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 110. EGYPT IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 111. EGYPT IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 112. EGYPT IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. FINLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 114. FINLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. FINLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 116. FINLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. FRANCE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 118. FRANCE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. FRANCE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 120. FRANCE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 122. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 123. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 124. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 128. ISRAEL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. ITALY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 130. ITALY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. ITALY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 132. ITALY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 140. NIGERIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. NORWAY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 142. NORWAY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. NORWAY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 144. NORWAY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. POLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 146. POLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 147. POLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 148. POLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. QATAR IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 150. QATAR IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 151. QATAR IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 152. QATAR IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. SPAIN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 166. SPAIN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 167. SPAIN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 168. SPAIN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. SWEDEN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 172. SWEDEN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 176. SWITZERLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. TURKEY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 178. TURKEY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 179. TURKEY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 180. TURKEY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. IMMUNO ONCOLOGY ASSAYS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 190. IMMUNO ONCOLOGY ASSAYS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 191. IMMUNO ONCOLOGY ASSAYS MARKET LICENSE & PRICING

Companies Mentioned

Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
BioAgilytix Labs, LLC
Charles River Laboratories International, Inc.
ElsaLys Biotech S.A.
Eurofins DiscoverX Products, LLC
HTG Molecular Diagnostics, Inc.
Illumina, Inc.
Merck KGaA
NanoString Technologies, Inc.
NeoGenomics Laboratories, Inc.
PerkinElmer, Inc.
QIAGEN GmbH
Sartorius AG
Thermo Fisher Scientific, Inc.
Twist Bioscience Corporation

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	192
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 7.21 Billion
Forecasted Market Value ( USD ) by 2030	$ 16.93 Billion
Compound Annual Growth Rate	15.2%
Regions Covered	Global
No. of Companies Mentioned	16

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3257EUR$3,374USD£2,794GBP €3619EUR$3,749USD£3,104GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4125EUR$4,274USD£3,539GBP €4584EUR$4,749USD£3,932GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€4994EUR$5,174USD£4,284GBP €5549EUR$5,749USD£4,760GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5863EUR$6,074USD£5,029GBP €6514EUR$6,749USD£5,588GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7600EUR$7,874USD£6,519GBP €8445EUR$8,749USD£7,244GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global Immuno-Oncology Market by Type (Cancer Vaccines, Checkpoint Inhibitors, Cytokines), Indication (Breast Cancer, Colorectal Cancer, Lung Cancer), End-Users - Forecast 2024-2030

Global Immuno-oncology Clinical Trials Market by Design (Expanded Access Trials, Interventional Trials, Observational Trials), Phase (Phase I, Phase II, Phase III), Indication - Forecast 2024-2030

Immuno-Oncology - Global Strategic Business Report

Immuno-Oncology Clinical Trials Market Report 2023-2033

Global Immuno-oncology Market

About the Immuno Oncology Assays Market